IL33 and liver cancer: To investigate the role of IL-33 in HBV+DEN-induced liver cancer, we subjected Il33 knockout (Il33KO), ST2 knockout (ST2KO), and Il33 transcription factor, Irf3, knockout (Irf3KO) mice to HBV+DEN liver carcinogenesis protocol (Fig. 1a).